|
Originally published In Press as doi:10.1074/jbc.M804722200 on August 26, 2008
J. Biol. Chem., Vol. 283, Issue 46, 31657-31664, November 14, 2008
Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents*
Wei-hui Wu 1,
Peng Lei 12,
Qian Liu ,
Jia Hu ,
Adam P. Gunn ,
Mei-sha Chen ,
Yan-fang Rui ¶,
Xiao-yang Su ,
Zuo-ping Xie¶,
Yu-Fen Zhao ,
Ashley I. Bush 3, and
Yan-mei Li 4
From the
Departments of Chemistry and ¶Biological Science and Biotechnology, Tsinghua University, Beijing 100084, China, and the Mental Health Research Institute of Victoria, and Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia
Decelerated degradation of β-amyloid (Aβ) and its interaction with synaptic copper may be pathogenic in Alzheimer disease. Recently, Co(III)-cyclen tagged to an aromatic recognition motif was shown to degrade Aβ in vitro. Here, we report that apocyclen attached to selective Aβ recognition motifs (KLVFF or curcumin) can capture copper bound to Aβ and use the Cu(II) in place of Co(III) to become proteolytically active. The resultant complexes interfere with Aβ aggregation, degrade Aβ into fragments, preventing H2O2 formation and toxicity in neuronal cell culture. Because Aβ binds Cu in amyloid plaques, apocyclen-tagged targeting molecules may be a promising approach to the selective degradation of Aβ in Alzheimer disease. The principle of copper capture could generalize to other amyloidoses where copper is implicated.
Received for publication, June 20, 2008
, and in revised form, July 25, 2008.
* This work was supported by National Natural Science Foundation of China Grants 20825206 and 20672067 and by an Australian Research Council Federation fellowship and the National Health and Medical Research Council (to A. I. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental "Experimental Procedures," Table S1, and Fig. S1.
1 Both authors contributed equally to this work.
2 Present address: Mental Health Research Institute of Victoria and Dept. of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia.
3 To whom correspondence may be addressed: Oxidation Biology Laboratory, Mental Health Research Institute of Victoria, 155 Oak St., Parkville, Victoria 3052, Australia. Tel.: 61-3-9389-2914; Fax: 61-3-9387-5061; E-mail: abush{at}mhri.edu.au. 4 To whom correspondence may be addressed: Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua University, Beijing 100084, China. Tel.: 86-10-6279-6197; Fax: 86-10-6278-1695; E-mail: liym{at}mail.tsinghua.edu.cn.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|